Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Korábbi kezelés

• Intraocular surgery (including intraocular lens implantation surgery) within 3 months prior to randomization.

Más betegség

• Retinal disease other than dry AMD.
• Any ophthalmologic condition that prevents adequate imaging of the retina as judged by the study site or central reading center.
• Any ophthalmic condition that will or is likely to require surgery during the study period.
• Hypersensitivity to fluorescein.
• Suspected or known allergy to any components of the study treatments.
• History of vitrectomy surgery, submacular surgery or any other surgical intervention for dry AMD.
• History of glaucoma filtering surgery or corneal transplant in the study eye.
• History of central serous retinopathy in either eye.

Egyéb

• GA due to causes other than dry AMD.
• Any history or current evidence of exudative ("wet") AMD.

• Age ≥50 years at time of informed consent.
• BCVA of 24 letters or better using Early Treatment Diabetic Retinopathy Study (ETDRS) charts at screening.
• Stable pharmacological treatment of any other chronic conditions for at least 30 days prior to screening.